Cargando…
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clust...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675493/ https://www.ncbi.nlm.nih.gov/pubmed/34911571 http://dx.doi.org/10.1186/s13073-021-01001-x |
_version_ | 1784615881387540480 |
---|---|
author | Fustero-Torre, Coral Jiménez-Santos, María José García-Martín, Santiago Carretero-Puche, Carlos García-Jimeno, Luis Ivanchuk, Vadym Di Domenico, Tomás Gómez-López, Gonzalo Al-Shahrour, Fátima |
author_facet | Fustero-Torre, Coral Jiménez-Santos, María José García-Martín, Santiago Carretero-Puche, Carlos García-Jimeno, Luis Ivanchuk, Vadym Di Domenico, Tomás Gómez-López, Gonzalo Al-Shahrour, Fátima |
author_sort | Fustero-Torre, Coral |
collection | PubMed |
description | We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-01001-x. |
format | Online Article Text |
id | pubmed-8675493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86754932021-12-20 Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data Fustero-Torre, Coral Jiménez-Santos, María José García-Martín, Santiago Carretero-Puche, Carlos García-Jimeno, Luis Ivanchuk, Vadym Di Domenico, Tomás Gómez-López, Gonzalo Al-Shahrour, Fátima Genome Med Method We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-01001-x. BioMed Central 2021-12-16 /pmc/articles/PMC8675493/ /pubmed/34911571 http://dx.doi.org/10.1186/s13073-021-01001-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Method Fustero-Torre, Coral Jiménez-Santos, María José García-Martín, Santiago Carretero-Puche, Carlos García-Jimeno, Luis Ivanchuk, Vadym Di Domenico, Tomás Gómez-López, Gonzalo Al-Shahrour, Fátima Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title | Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title_full | Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title_fullStr | Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title_full_unstemmed | Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title_short | Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data |
title_sort | beyondcell: targeting cancer therapeutic heterogeneity in single-cell rna-seq data |
topic | Method |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675493/ https://www.ncbi.nlm.nih.gov/pubmed/34911571 http://dx.doi.org/10.1186/s13073-021-01001-x |
work_keys_str_mv | AT fusterotorrecoral beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT jimenezsantosmariajose beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT garciamartinsantiago beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT carreteropuchecarlos beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT garciajimenoluis beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT ivanchukvadym beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT didomenicotomas beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT gomezlopezgonzalo beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata AT alshahrourfatima beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata |